October 23, 2016 8:35 AM ET

Healthcare Equipment and Supplies

Company Overview of CardioDx, Inc.

Company Overview

CardioDx, Inc., a molecular diagnostics company, develops tests for coronary artery disease (CAD), cardiac arrhythmia, and heart failure. It develops Corus CAD, a blood test that helps primary care clinicians and cardiologists to assess whether or not non-diabetic patient’s chest discomfort or other symptoms are due to obstructive CAD. The company serves customers in the United States. CardioDx, Inc. was incorporated in 2003 and is based in Redwood City, California.

600 Saginaw Drive

Redwood City, CA 94063

United States

Founded in 2003

146 Employees


650 475 2788


650 475 2799

Key Executives for CardioDx, Inc.

Chief Executive Officer, President and Director
Founder and Chief Strategy Officer
Age: 56
Chief Financial Officer
Age: 58
Chief Medical Officer
Age: 55
Head of Research and Vice President of Technical Operations
Compensation as of Fiscal Year 2016.

CardioDx, Inc. Key Developments

CardioDx, Inc. Announces Management Changes

CardioDx, Inc. announced the appointment of Khush Mehta as President, Chief Executive Officer, and a member of the Board of Directors of the company. With a proven track record for commercial success and execution in the global healthcare industry, Mehta will help drive the organization to the next level of commercial growth, value creation for its stakeholders, and the expansion of the company's product portfolio through innovation and partnerships. He will focus on overseeing the day-to-day operations and accelerating profitable growth in the near and long-term. As CEO, Mehta succeeds David Levison, who has been named the Chief Strategy Officer of the company. As the Chief Strategy Officer, Levison, the founder of CardioDx, will lead the company in business development, health payer coverage, and next generation technology.

CardioDx Appoints Timothy Henn as Chief Financial Officer

CardioDx has appointed Timothy Henn as Chief Financial Officer of the company. The company noted yjay Henn is a seasoned executive in the healthcare industry, including experience with both private and public companies. Prior to joining CardioDx, he served as Chief Financial Officer of Crescendo Biosciences.

CardioDx, Inc. and Quest Diagnostics Sign Agreement to Expand Patient Access to the Corus Cad Test

CardioDx, Inc. announced a national specimen-draw agreement with Quest Diagnostics that will expand patient and clinician access to the Corus CAD lab-developed blood test for aiding the assessment of obstructive coronary artery disease (CAD). Under a multi-year agreement, clinicians will be able to order blood draws on patients for testing through Quest's approximately 2,200 patient service centers and 4,000 phlebotomists in physician offices in the United States. Samples will be forwarded to CardioDx's CLIA-certified laboratory (in Redwood City, Calif.) for testing.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CardioDx, Inc., please visit www.cardiodx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.